InsidersTradesSigma
Follow the 바이오솔루션 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이오솔루션 has recorded 1 public disclosures. Market capitalisation: €150.7bn. The latest transaction was filed on 12 March 2026 (Other). Among the most active insiders: 바이오솔루션. The full history is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 22,827 of 29,064 companies
31.8
score / 100
Value25
Quality39
FCF yld-1.4%
Earn yld0.2%
EV/EBITDA34.3x
ROE-2.5%
Gross mgn63%
Net mgn1.8%
Debt/EBITDA5.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 March 2026
Acerca de 바이오솔루션
BioSolution es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones biológicas innovadoras.